The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Matthew N. Hill(Allen Institute for Brain Science), Gabriella Gobbi(McGill University), Sachin Patel(Vanderbilt University Medical Center), Cecilia J. Hillard(Medical College of Wisconsin), Francis Rodriguez Bambico(Université de Montréal), Boris B. Gorzalka(University of British Columbia)
Cited by 175
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Neurobiological Interactions Between Stress and the Endocannabinoid System
|Neuropsychopharmacology|2015|644
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
|Neuropsychopharmacology|2017|450